IntelligentMDx Obtains $3,000,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a0f0f79e-93ab-48d8-84c7-66aa7994c283&Preview=1 -
Date
6/29/2009 -
Company Name
IntelligentMDx -
Mailing Address
19 Blackstone Street Cambridge, MA 02139 -
Company Description
IntelligentMDx’s competitive advantage is in the production of superior performing tests with significantly faster time to market. Embedded in our approach is a bioinformatics process that uses mathematical algorithms to predict test failure and simulate real life conditions such as contamination or genetic mutations that would impact test functionality. IntelligentMDx’s current pipeline includes proprietary nucleic acid (DNA or RNA) tests for Real Time PCR. IntelligentMDx has a pipeline of single test (singleplex) and multi-test (multiplex), diagnostic solutions for a wide range of human diseases. We have built our product candidate portfolio through internal discovery and are advancing our product candidates through in-house R&D. -
Website
http://www.intelligentmdx.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$3,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
